The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
The trialists all gradually converting this year as budget allows will be a great foundation to stand on and build on. We hopefully get a steady stream of de novo systems like the one already received
Bastians Duke is very close to conversion from trial to paid system. That's a nailed on sale in the coming days or weeks
More buying than being presented by the dodgy mms. Plenty buys are going through as sells in typical smoke and mirrors fashion
Https://www.share-talk.com/the-buyout-targets-of-2024/
It is an option. But new investors at this level. Give your head a wobble if you haven't bought or topped up taking advantage of this ludicrous overdone dip
Plenty coming in. Should hopefully be reducing todays damage and its just a blip.
Jumped in a tad early today. But buyers coming in at this crazy level. It's difficult to take for shareholders I share your pain. Let us hope its the worst and its only temporary pain. Bastiaan got to be feeling likewise ... maybe not but he has enormous confidence and 5m shares
I expect Duke conversion to full system take up is now incredibly close. Expect this further evidence of commercialism prior to any funding
Well done nova. There is strong support from the British Heart foundation and u.s counterpart the fda approval will be helped along perhaps by them this is important tech for this new sector. Everything is expanding at polx this is a great top up time don't miss it imo.
I've happily topped up an hefty chunk. Market reaction overdone. Very happy with update strategic partner support. Nukem happy to add again to their increased shareholding. These people know more than little pri cks and b itches on here. Good luck all holders and real supporters of this tech and company. You will rewarded particularly from today's way overdone manipulation
hTtps://clinicaltrials.gov/study/NCT06271408?term=polarean&rank=4
Courtesy tutte advfn. Interesting. We're going to have some pleasant surprises here as the expanding procedures across further disciplines emerge.
Ooo we're all so scared after the shameless tree shake. They mess with the spread a lot here
Noticed the massive jump on offer . Think they need shares
Pent up. Strong buy at a bargain level for the future. Happy to have msde my first purchases in the last few days. The analysis coverage an extra speed boost
Bet me
This won't dampen enthusiasm... ubs starts coverage buy. Price target 450p ;)
poor little moaning *****
If you have any sense
I couldn't buy yesterday directly. But they were happy to quote for entire holding
Why?